Difference between revisions of "Cao B, et al, N Engl J Med (2020), cited as Ref 11 in DOI: 10.1016/j.clim.2020.108427 (Q11254)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2020, #quickstatements; #temporary_batch_1593100957390) |
(Created claim: DOI Identifier (P138): 101056/NEJMoa2001282, #quickstatements; #temporary_batch_1593105530610) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / First Author string | |||
| + | Cao B | ||
| Property / First Author string: Cao B / rank | |||
| + | Normal rank | ||
| Property / title | |||
| + | A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19 (English) | ||
| Property / title: A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19 (English) / rank | |||
| + | Normal rank | ||
| Property / DOI Identifier | |||
| + | |||
| Property / DOI Identifier: 101056/NEJMoa2001282 / rank | |||
| + | Normal rank | ||
Latest revision as of 17:18, 25 June 2020
Cited in: "COVID-19 pathophysiology: A review" Clin Immunol; 2020 Apr 20 108427.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Cao B, et al, N Engl J Med (2020), cited as Ref 11 in DOI: 10.1016/j.clim.2020.108427
|
Cited in: "COVID-19 pathophysiology: A review" Clin Immunol; 2020 Apr 20 108427.
|
Statements
N Engl J Med
0 references
2020
0 references
Cao B
0 references
A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19 (English)
0 references
